Innovation Pharmaceuticals Inc (IPIX)

[Jhawker]

I think it's interesting listening to the debate about the P2b study and compare it to the B ABBSSI study discussions. It definitely wasn't a fore gone conclusion that the study was going to be a success. The B2a had many issues and many question marks. At the time many of the "scientific" posters only gave it a 60% chance at best of success. The company has done a great job working with limited resources and moving the trials forward.